Article info

PDF

Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study

Authors

  1. Correspondence to Dr Murray B Urowitz; m.urowitz{at}utoronto.ca
View Full Text

Citation

Urowitz MB, Isenberg DA, Wallace DJ
Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study

Publication history

  • Received 20 May 2015
  • Revision received 6 July 2015
  • Accepted 10 July 2015
  • Published in print 1 August 2015.
  • Published online 11 August 2015.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.